Epstein David R
5 of 15 shown
The 5 most recent of 15 visible filings, newest first.
- AgomAb Therapeutics NV Director$29,859Open-market buy
- AgomAb Therapeutics NV Director$28,750Open-market buy
- AgomAb Therapeutics NV Director$120Open-market buy
- AgomAb Therapeutics NV Director$29,950Open-market buy
- AgomAb Therapeutics NV Director$34,900Open-market buy